Literature DB >> 7865458

Analysis of natural and disease-associated autoantibody repertoires: anti-endothelial cell IgG autoantibody activity in the serum of healthy individuals and patients with systemic lupus erythematosus.

N Ronda1, M Haury, A Nobrega, S V Kaveri, A Coutinho, M D Kazatchkine.   

Abstract

The present study demonstrates that natural IgG with anti-endothelial cell activity is present in the serum of healthy individuals and in pooled normal human Ig. By using a novel method that allows for the simultaneous and quantitative assessment of reactivities of antibodies with a large number of antigens in tissues, we observed that natural anti-endothelial cell antibody (AECA) recognizes a restricted set of self antigens in endothelial cells that is conserved among healthy individuals. The extent to which natural AECA activity is expressed in serum and the pattern of reactivity of AECA with endothelial cell antigens showed little variability between individuals. Analysis of AECA in the serum of patients with systemic lupus erythematosus (SLE) revealed a higher amount of activity and a wider spectrum of antigenic specificities than that recognized by natural antibodies in endothelial cell extracts. AECA activity of IgG in whole serum was lower than that of purified IgG in the case of healthy individuals and showed little variation among individuals. In contrast, no difference was found between AECA activity of purified IgG and that of IgG in patients' serum suggesting that SLE sera lack the factors that control expression of AECA activity in the serum of healthy individuals. Our results indicate that natural autoantibodies recognize a restricted and conserved set of self antigens. Our observations further suggest that defective regulation of the expressed autoreactive B cell repertoire is the basis for expansion of novel clonal specificities and enhanced autoantibody activity in serum of patients with autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7865458     DOI: 10.1093/intimm/6.11.1651

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  13 in total

1.  Functional heterogeneity of anti-endothelial cell antibodies.

Authors:  A Bordron; R Révélen; F D'Arbonneau; M Dueymes; Y Renaudineau; C Jamin; P Youinou
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

Review 2.  Immunomodulatory action of intravenous immunoglobulin.

Authors:  W A C Sewell; S Jolles
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

Review 3.  Intravenous immunoglobulin and multiple sclerosis.

Authors:  Anat Achiron; Shmuel Miron
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

4.  IgM-enriched human intravenous immunoglobulin suppresses T lymphocyte functions in vitro and delays the activation of T lymphocytes in hu-SCID mice.

Authors:  T Vassilev; N Mihaylova; E Voynova; M Nikolova; M Kazatchkine; S Kaveri
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

Review 5.  HSP60 and anti-HSP60 antibodies in vasculitis: they are two of a kind.

Authors:  Jean-Eric Alard; Maryvonne Dueymes; Pierre Youinou; Christophe Jamin
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

Review 6.  Targeted Therapies for Autoimmune Bullous Diseases: Current Status.

Authors:  Kyle T Amber; Roberto Maglie; Farzan Solimani; Rüdiger Eming; Michael Hertl
Journal:  Drugs       Date:  2018-10       Impact factor: 9.546

7.  Normal human IgG prevents endothelial cell activation induced by TNFalpha and oxidized low-density lipoprotein atherogenic stimuli.

Authors:  N Ronda; F Bernini; R Giacosa; R Gatti; N Baldini; C Buzio; G Orlandini
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

8.  Lupus-specific kidney deposits of HSP90 are associated with altered IgG idiotypic interactions of anti-HSP90 autoantibodies.

Authors:  A Kenderov; V Minkova; D Mihailova; N Giltiay; S Kyurkchiev; I Kehayov; M Kazatchkine; S Kaveri; A Pashov
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

Review 9.  Antiendothelial cells autoantibodies in vasculitis-associated systemic diseases.

Authors:  Philippe Guilpain; Luc Mouthon
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

10.  Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement.

Authors:  M R Weiser; J P Williams; F D Moore; L Kobzik; M Ma; H B Hechtman; M C Carroll
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.